UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 17, 2015
SABRA HEALTH CARE REIT, INC.
(Exact name of registrant as specified in its charter)
Maryland | 001-34950 | 27-2560479 | ||
(State of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
18500 Von Karman Avenue, Suite 550 Irvine, CA | 92612 | |
(Address of principal executive offices) | (Zip Code) | |
Registrant's telephone number including area code: (888) 393-8248
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders
(a) The annual meeting of stockholders (the “Annual Meeting”) of Sabra Health Care REIT, Inc. (the “Company”) was held on June 17, 2015.
(b) At the Annual Meeting, the Company’s stockholders (a) elected the five nominees identified in the table below to the Board of Directors of the Company to serve until the Company’s 2016 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“Election of Directors”), (b) ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015 (“Auditor Ratification”), and (c) approved, on an advisory basis, the compensation of the Company’s named executive officers as set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2015 (“Advisory Compensation Vote”). Set forth below are the final voting tallies for the Annual Meeting:
Election of Directors
For | Against | Abstain | Broker Non-Votes | |||||
Craig A. Barbarosh | 51,534,173 | 179,282 | 22,755 | 4,212,530 | ||||
Robert A. Ettl | 49,711,667 | 2,001,691 | 22,852 | 4,212,530 | ||||
Michael J. Foster | 51,507,559 | 205,058 | 23,593 | 4,212,530 | ||||
Richard K. Matros | 47,476,664 | 2,387,652 | 1,871,894 | 4,212,530 | ||||
Milton J. Walters | 51,498,475 | 214,990 | 22,745 | 4,212,530 | ||||
Auditor Ratification
For | Against | Abstain | ||
55,564,635 | 358,456 | 25,649 | ||
Advisory Compensation Vote
For | Against | Abstain | Broker Non-Votes | ||||
49,524,268 | 2,092,069 | 119,873 | 4,212,530 | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SABRA HEALTH CARE REIT, INC. | |||
/S/ Harold W. Andrews, Jr. | |||
Name: | Harold W. Andrews, Jr. | ||
Title: | Executive Vice President, Chief Financial Officer and Secretary | ||
Dated: June 17, 2015